ATC codes:
P02CA03
EMLc
Indication
Cysticercosis of central nervous system
ICD11 code:
1F70.0
INN
Albendazole
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid > tablet:
400 mg (chewable, scored) ;
200 mg (chewable)
(EMLc)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listings for albendazole 400 mg chewable tablets on the EML and EMLc be amended to specify that they be scored.
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the the addition of a new strength formulation (200 mg chewable tablets) to the EMLc for treatment of diseases caused by taeniid cestode cysts.